Mitochondria-targeted drug delivery systems for aging-related diseases: Mechanisms, strategies, and advances
Journal of Controlled Release · 2026-11 · 399 · 115463
DOI: 10.1016/j.jconrel.2026.115463 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Fang Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, …. Hauptthemen laut MEDLINE: Aging, Mitochondria, Drug Delivery Systems. Die Arbeit nennt 138 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Health and Family Planning Commission of Sichuan Province, Southwest Minzu University.
Abstract (Originalsprache)
Mitochondrial dysfunction, characterized by increased oxidative stress, impaired energy metabolism, disrupted mitochondrial dynamics, abnormal quality control, and activation of apoptosis, represents a critical pathological basis for a wide range of aging-related diseases (ARDs), including neurodegenerative diseases, cardiovascular disorders, sarcopenia, and osteoarthritis. Mitochondria-targeted drug delivery systems increase the effective concentration of bioactive molecules within these dysfunctional organelles, offering novel strategies for the precise modulation of mitochondrial function. This review summarizes structural and functional changes in mitochondria during aging and their associations with major ARDs. We comprehensively review key advances in the design principles, mechanisms of action, and applications of passive targeting, stimuli-responsive systems, active targeting, and biomimetic drug delivery platforms. In addition, emerging interventions such as NAD+ supplementation, mitochondrial gene delivery, EV-mediated mitochondrial delivery and mitochondrial transplantation are discussed. Despite the demonstrated potential of these systems to restore mitochondrial homeostasis and tissue functionality in various disease models, their clinical translation remains constrained by obstacles including unstable targeting efficacy under pathological conditions, insufficient long-term safety of materials, manufacturing complexity, and a lack of standardized evaluation criteria. Future efforts should focus on integrating disease heterogeneity, advanced materials, and multi-omics technologies to advance mitochondria-targeted therapies toward standardization, individualization, and diagnostic-therapeutic integration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, Southwest Minzu University, Chengdu, 610041, China.
- College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, Southwest Minzu University, Chengdu, 610041, China. Electronic address…
- Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic…
Förderung
- National Natural Science Foundation of China
- Health and Family Planning Commission of Sichuan Province
- Southwest Minzu University
- Sichuan Provincial Administration of Traditional Chinese Medicine
Zitieren
APA
Zhang, F., Ma, H., Zhou, S., Ran, S., Abulajiang, M., Li, S., & Zhang, Q. (2026). Mitochondria-targeted drug delivery systems for aging-related diseases: Mechanisms, strategies, and advances. Journal of Controlled Release, 399, 115463. https://doi.org/10.1016/j.jconrel.2026.115463
Vancouver
Zhang F, Ma H, Zhou S, Ran S, Abulajiang M, Li S, et al. Mitochondria-targeted drug delivery systems for aging-related diseases: Mechanisms, strategies, and advances. Journal of Controlled Release. 2026;399:115463. doi:10.1016/j.jconrel.2026.115463
BibTeX
@article{Zhang2026,
author = {Zhang, Fang and Ma, Haotian and Zhou, Siyu and Ran, Shasha and Abulajiang, Maiheliya and Li, Shanshan and Zhang, Qixiong},
title = {Mitochondria-targeted drug delivery systems for aging-related diseases: Mechanisms, strategies, and advances},
journal = {Journal of Controlled Release},
year = {2026},
volume = {399},
pages = {115463},
doi = {10.1016/j.jconrel.2026.115463}
}
EUVIMED